Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Contemp Clin Trials. 2019 Aug 7;84:105820. doi: 10.1016/j.cct.2019.105820

Table A.3.

Participant healthcare resource utilization one month after the first return visit by types of results returned

In the past month Genetic Testing Results1
Positive (P/LP)
N=17(%)
VUS
N=25(%)
Negative
N=84(%)
Number of visits to a specialist doctor
0 13(74.5) 14(63.6) 49 (58.3)
1 2(11.8) 6(27.3) 21(25.0)
2 1(5.9) 1(4.6) 6(7.1)
3 1(5.9) 0(0) 8(9.5)
Missing 0(0) 1(4.6) 0(0)
Number of visits to a genetic counselor
0 14(82.4) 15(68.2) 58(69.1)
1 3(17.7) 5(22.7) 23(27.4)
2 0(0) 0(0) 2(2.4)
3 0(0) 1(4.6) 0(0)
Missing 0(0) 1(4.6) 1(1.2)
Had any medical procedures
No 14(82.4) 18(84.8) 56(66.7)
Yes 3(17.7) 4(18.2) 27(32.1)
Missing 0(0) 0(0) 1(1.2)
Had any evaluation of cancer
No 15(88.2) 17(77.3) 60(71.4)
Yes 2(11.8) 5(22.7) 24(28.6)
Health insurance changes
Have made 0(0) 2(9.1) 5(6.0)
Intend to 3(17.7) 1(4.6) 4(4.8)
Thought about 0(0) 2(9.1) 3(3.6)
Have not 14(82.4) 17(77.3) 72(85.7)
Life insurance changes
Have made 0(0) 0(0) 6(7.1)
Intend to 0(0) 1(4.6) 2(2.4)
Thought about 3(17.7) 2(9.1) 4(4.8)
Have not 14(82.4) 19(86.4) 72(85.7)
Shared genetic test
results with 1st-degree
blood family members
No 3(17.7) 5(22.7) 20(23.8)
Yes 14(82.4) 17(77.3) 64(76.2)
1.

Genetic testing results included both CRCP and non-CRCP findings